Kolexia
Piperno-Neumann Sophie Oncologie médicale
Piperno-Neumann Sophie
Oncologie médicale
Clcc Institut Curie
Paris, France
359 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Mélanome Tumeurs de l'uvée Métastase tumorale Ostéosarcome Léiomyosarcome Tumeurs osseuses Récidive tumorale locale Fibromatose agressive

Collaborateurs

Voir plus
Blay Jean Yves
Blay Jean Yves
Centre Léon-Bérard, Lyon, France
Penel Nicolas
Penel Nicolas
Centre Oscar-Lambret, Lille, France
Italiano Antoine
Italiano Antoine
Institut Bergonié, Bordeaux, France
Le Cesne Axel
Le Cesne Axel
Gustave-Roussy, Villejuif, France

Industries

Voir plus
IMMUNOCORE IRELAND LTD
11 collaboration(s)
Dernière en 2023
NEXTEP
2 collaboration(s)
Dernière en 2022
CanceroDigest
2 collaboration(s)
Dernière en 2023
Pierre Fabre
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma: IDE196 (Darovasertib) in Combination With Crizotinib Versus Investigator's Choice of Treatment as First-line Therapy in HLA-A2 Negative Metastatic Uveal Melanoma (DAR-UM-2)
Essai Clinique (IDEAYA Biosciences)   18 mars 2024
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma: A Phase II Randomized, Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Compared With Investigator Choice in HLA-A*0201 Positive Patients With Previously Untreated Advanced Uveal Melanoma
Essai Clinique (Immunocore Ltd)   06 mars 2024
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN.
The Lancet regional health. Europe   16 février 2024
COTESARC: A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Essai Clinique (Centre Léon-Bérard)   09 février 2024
SARCOME13: Multicentre, Randomised, Phase 2 Trial of Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients (Metastatic Osteosarcoma at Diagnosis or Localised Disease With Poor Histological Response)
Essai Clinique (Unicancer)   01 février 2024
Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma: Development and Validation of a Circulating Tumor DNA Detection Technique in Patients With Metastatic Choroidal Melanoma
Essai Clinique (Institut Curie)   29 janvier 2024
SALOME: Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
Essai Clinique (Institut Curie)   29 janvier 2024
Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0): Study to Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (R0)
Essai Clinique (Institut Curie)   29 janvier 2024
Vismodegib in Treating Patients With Advanced Chondrosarcomas: A Phase 2 Study of GDC-0449 in Patients With Advanced Chondrosarcomas
Essai Clinique (National Cancer Institute)   26 janvier 2024
Improved nationwide survival of sarcoma patients with a network of reference centers.
Annals of oncology : official journal of the European Society for Medical Oncology   19 janvier 2024